Companies House does not verify the accuracy of the information filed

UROVANT HOLDINGS LIMITED

Company number 10457662

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
19 Nov 2024	GAZ1(A)	First Gazette notice for voluntary strike-off This document is being processed and will be available in 10 days.
07 Nov 2024	DS01	Application to strike the company off the register	View PDF Application to strike the company off the register - link opens in a new window - 1 page (1 page)
05 Nov 2024	CS01	Confirmation statement made on 2 November 2024 with no updates	View PDF Confirmation statement made on 2 November 2024 with no updates - link opens in a new window - 3 pages (3 pages)
14 Aug 2024	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
14 Aug 2024	SH19	Statement of capital on 14 August 2024 USD 205.65	View PDF Statement of capital on 14 August 2024 USD 205.65 - link opens in a new window - 3 pages (3 pages)
14 Aug 2024	CAP-SS	Solvency Statement dated 13/08/24	View PDF Solvency Statement dated 13/08/24 - link opens in a new window - 2 pages (2 pages)
14 Aug 2024	RESOLUTIONS	Resolutions RES13 ‐ Cancel share premium account 13/08/2024	View PDF Resolutions RES13 ‐ Cancel share premium account 13/08/2024 - link opens in a new window - 2 pages (2 pages)
30 Dec 2023	AA	Full accounts made up to 31 March 2023	View PDF Full accounts made up to 31 March 2023 - link opens in a new window - 20 pages (20 pages)
06 Dec 2023	CS01	Confirmation statement made on 2 November 2023 with updates	View PDF Confirmation statement made on 2 November 2023 with updates - link opens in a new window - 5 pages (5 pages)
06 Oct 2023	TM01	Termination of appointment of Mark Craig as a director on 6 October 2023	View PDF Termination of appointment of Mark Craig as a director on 6 October 2023 - link opens in a new window - 1 page (1 page)
06 Oct 2023	AP01	Appointment of Ms Emma Carys Price as a director on 6 October 2023	View PDF Appointment of Ms Emma Carys Price as a director on 6 October 2023 - link opens in a new window - 2 pages (2 pages)
25 Sep 2023	SH19	Statement of capital on 25 September 2023 USD 205.65	View PDF Statement of capital on 25 September 2023 USD 205.65 - link opens in a new window - 5 pages (5 pages)
25 Sep 2023	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
25 Sep 2023	CAP-SS	Solvency Statement dated 22/09/23	View PDF Solvency Statement dated 22/09/23 - link opens in a new window - 2 pages (2 pages)
25 Sep 2023	RESOLUTIONS	Resolutions RES13 ‐ Reduce share premium 22/09/2023	View PDF Resolutions RES13 ‐ Reduce share premium 22/09/2023 - link opens in a new window - 5 pages (5 pages)
21 Apr 2023	RP04CS01	Second filing of Confirmation Statement dated 2 November 2022	View PDF Second filing of Confirmation Statement dated 2 November 2022 - link opens in a new window - 3 pages (3 pages)
13 Apr 2023	SH01	Statement of capital following an allotment of shares on 30 March 2023 USD 205.65	View PDF Statement of capital following an allotment of shares on 30 March 2023 USD 205.65 - link opens in a new window - 3 pages (3 pages)
16 Dec 2022	AA	Full accounts made up to 31 March 2022	View PDF Full accounts made up to 31 March 2022 - link opens in a new window - 20 pages (20 pages)
30 Nov 2022	CS01	Confirmation statement made on 2 November 2022 with updates ANNOTATION Clarification a second filed CS01 (Statement of Capital and Shareholder Information) was registered on 21/04/23	View PDF Confirmation statement made on 2 November 2022 with updates ANNOTATION Clarification a second filed CS01 (Statement of Capital and Shareholder Information) was registered on 21/04/23 - link opens in a new window - 6 pages (6 pages)
12 Oct 2022	AD01	Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022	View PDF Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022 - link opens in a new window - 1 page (1 page)
03 Oct 2022	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
03 Oct 2022	SH19	Statement of capital on 3 October 2022 USD 205.64	View PDF Statement of capital on 3 October 2022 USD 205.64 - link opens in a new window - 5 pages (5 pages)
03 Oct 2022	CAP-SS	Solvency Statement dated 21/09/22	View PDF Solvency Statement dated 21/09/22 - link opens in a new window - 2 pages (2 pages)
03 Oct 2022	RESOLUTIONS	Resolutions RES13 ‐ Cancel share prem a/c 21/09/2022 RES06 ‐ Resolution of reduction in issued share capital	View PDF Resolutions RES13 ‐ Cancel share prem a/c 21/09/2022 RES06 ‐ Resolution of reduction in issued share capital - link opens in a new window - 2 pages (2 pages)
22 Apr 2022	PSC02	Notification of Sumitomo Pharma Co., Ltd. as a person with significant control on 30 March 2021	View PDF Notification of Sumitomo Pharma Co., Ltd. as a person with significant control on 30 March 2021 - link opens in a new window - 2 pages (2 pages)

Cookies on Companies House services

UROVANT HOLDINGS LIMITED

Filter by category